News about Biotechnology, Pharmaceutical and Healthcare

New HIV guidelines make screening even more routine

Guidelines call for screening adolescents and adults ages 15 to 65 who are not known to be at increased risk for HIV infection.

Disparities seen in treatment of hypertension

Prevention campaign offers doctors tools to fight obesity

Comparative effectiveness research funds awarded

Senators ask Medicare to use bonds to recoup overpayments

Revealed names expose flaw in de-identified patient data

A researcher finds a way to attach identities to nameless records, but information collected by physician practices is not likely to carry the same risks.

Mobile a likely key to more patient portal use

Some hospitals have been successful by launching apps that give patients access to their medical records. Physician practices might find similar interest.

Proteintech Europe awarded a Quality Certificate for the ISO 9001: 2008 standard

Proteintech Europe are pleased to announce that they have been awarded ISO 9001:2008 BSI Accreditation. The award was made through URS Certification (http://www.urscertification.com/) a world leader in assessing business processes against internation...

BIBA fever as Blackpool firm wins three finalist places

An SMO business has reached the final shortlist in Lancashire’s premier business awards.MAC Clinical Research, based in the Bispham area of Blackpool, have been finalised in a hat-trick of categories including Creative Business, E-Business and...

New informative sessions on Design Health Barcelona training program

d·HEALTH Barcelona seeks radical change in innovation in the healthcare sector. It goes beyond traditional classes and submerges participants in a hospital setting, where they will gain first-hand experience of...

How can we control the spread of malaria caused by 'Plasmodium vivax'?

The New York Academy of Sciences, the "la Caixa" Foundation, B·Debate and ISGlobal are holding a conference with some twenty of the top global experts in malaria research on 28 and 29 May in Barcelona....

Thermo Fisher Scientific Introduces Next Generation Ion Chromatography Suppressor

Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Thermo Scientific™ Dionex™ ERS™ 500 Electrolytically Regenerated Suppressor which replaces the Thermo Scientific™ Dionex™ SRS™ 300 Self Regenerating Suppressor. The Dionex ERS 500 Suppressor minimizes dispersion to deliver higher resolution separations, especially when coupled wi...

Avacta systems dramatically save time on formulation studies in Korea

Scientists at the specialised biotech company PharmAbcine are completing formulation and stability studies in a fraction of the time thanks to an Optim 1000 microvolume protein analysis and characterisation instrument from Avacta Analytical. PharmAbcine was established in the Republic of Korea in 2008 specifically for the development of human monoclonal antibodies into drugs for the treatment of h...

Merck Millipore to Highlight Capabilities in LC-MS at ASMS

Merck Millipore highlights its new ZIC®-HILIC technology, a zwitterionic HILIC phase for LC-MS separation of polar compounds. Merck Millipore offers a comprehensive portfolio of reliable and reproducible LC-MS separation tools even for the most challenging analysis problems in research and development, quality control, environmental, clinical and biochemical analysis.Merck Millipore will host...

Sanofi fined for discouraging generic clopidogrel prescriptions

On 14 May 2013, French drugmaker sanofi-aventis was fined Euros 40.6 million by the French competition authority (L’Autorité de la concurrence) for marketing practices that discouraged sales of generic versions of its blood thinner Plavix (clopido...

Australia reviews chemotherapy drug subsidies

The Australian Government announced on 5 May 2013 a major review into the way chemotherapy drugs are funded.

US places India on IP black list

The US has placed India on a special trade black list of countries that have raised concerns about intellectual property rights.

Actavis in discussions to buy Warner Chilcott

US generics maker Actavis (formerly Watson) confirmed on 14 May 2013 that the company had entered into discussions to buy Irish drugmaker Warner Chilcott.

FDA rejects Endo petition to stop Opana ER generics

On 10 May 2013, FDA announced that it had rejected a petition by Endo Pharmaceuticals (Endo) to stop generics of its powerful painkiller, Opana ER (oxymorphone).

Updated guideline on the use of epoetin and darbepoetin in cancer patients

Patients undergoing chemotherapy for cancer can often become anaemic as their red blood cell counts, and hence iron levels, fall. Besides the traditional approach of offering blood transfusion in order to restore iron levels, physicians can now treat...

The biggest drug patent losses for 2013

During 2012–2018 over US$290 billion of sales are at risk from patent expirations.  In fact, in 2013 alone patents will expire on drugs with yearly sales of US$29 billion. Generics are expected to grab 70% of those sales.

Agila Biotech and Pfenex make biosimilars deal

Agila Biotech, a subsidiary of India-based Strides Arcolab, and US-based biotech firm Pfenex announced on 16 April 2013 that they had entered into a joint venture for biosimilars.

Porvair Sciences Announces Summer Show Program

Porvair Sciences has announced that its latest applications focused microplates and microplate equipment will be exhibited at Forum LABO, European Lab Automation  ASMS and HPLC 2013 Visitors to Porvair’s stands at these important events will be able to meet technical specialists, see the company's new UltraVap Mistral microplate evaporator, recently launched range of HPLC sample evapora...

States wade into disclosure rules on biosimilars

State medical societies have advocated that such bills include physician notification provisions. The FDA continues development of an approval pathway for follow-on biologics.

Yellow fever vaccination booster not needed

17 May 2013 -- The yellow fever ‘booster’ vaccination given ten years after the initial vaccination is not necessary, according to WHO.